-
EP4039807
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4039807
| EP4039807 - ANTISENSE OLIGONUCLEOTIDES USEFUL IN TREATMENT OF POMPE DISEASE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 08.07.2022 Database last updated on 19.10.2024 | Most recent event Tooltip | 25.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Erasmus University Rotterdam Medical Center Dr. Molewaterplein 50 3015 GE Rotterdam / NL | [2022/32] | Inventor(s) | 01 /
BERGSMA, Atze Jacobus 3015 GE Rotterdam / NL | 02 /
VAN DER WAL, Erik 3015 GE Rotterdam / NL | 03 /
PIJNAPPEL, Wilhelmus Wenceslaus Matthias 3015 GE Rotterdam / NL | 04 /
VAN DER PLOEG, Antje Tjitske 3015 GE Rotterdam / NL | 05 /
REUSER, Arnoldus 3015 GE Rotterdam / NL | [2022/32] | Representative(s) | V.O. P.O. Box 87930 2508 DH Den Haag / NL | [2022/32] | Application number, filing date | 21216612.8 | 10.06.2015 | [2022/32] | Priority number, date | WO2014NL50374 | 10.06.2014 Original published format: PCT/NL2014/050374 | EP20140177884 | 21.07.2014 Original published format: EP 14177884 | EP20140183589 | 04.09.2014 Original published format: EP 14183589 | [2022/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4039807 | Date: | 10.08.2022 | Language: | EN | [2022/32] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 11.07.2022 | Classification | IPC: | C12N15/11, C12N15/113, A61K31/7088, A61P3/00 | [2022/32] | CPC: |
C12N15/1137 (EP,CN,IL,KR,US);
C12N15/111 (EP,CN,IL,KR,US);
A61K31/7088 (CN,IL,KR);
A61P21/00 (EP,IL);
A61P3/00 (EP,IL);
C12Y302/0102 (EP,US);
C12N2310/11 (EP,CN,IL,KR,US);
C12N2310/321 (IL,US);
C12N2310/3233 (IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/32] | Title | German: | ZUR BEHANDLUNG DER POMPE-KRANKHEIT NÜTZLICHE ANTISENSE-OLIGONUKLEOTIDE | [2022/32] | English: | ANTISENSE OLIGONUCLEOTIDES USEFUL IN TREATMENT OF POMPE DISEASE | [2022/32] | French: | OLIGONUCLÉOTIDES ANTISENS UTILISÉS DANS LE TRAITEMENT DE LA MALADIE DE POMPE | [2022/32] | Examination procedure | 21.01.2022 | Examination requested [2022/32] | 26.01.2023 | Amendment by applicant (claims and/or description) | 26.01.2023 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP15732985.5 / EP3155100 | Fees paid | Renewal fee | 21.01.2022 | Renewal fee patent year 03 | 21.01.2022 | Renewal fee patent year 04 | 21.01.2022 | Renewal fee patent year 05 | 21.01.2022 | Renewal fee patent year 06 | 21.01.2022 | Renewal fee patent year 07 | 25.10.2022 | Renewal fee patent year 08 | 23.05.2023 | Renewal fee patent year 09 | 25.06.2024 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 30.06.2022 | 08 M06 Fee paid on 25.10.2022 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2006021724 (GENETHON [FR], et al) [A] 1-19 * the whole document *; | [XI]US2007243546 (CAO YANXIANG [US], et al) [X] 1-3,5,6,9 * paragraph [0056]; sequence 108634 * [I] 4,7,8,10; | [A]WO2011024077 (INST NAT SANTE RECH MED [FR], et al) [A] 1-19 * the whole document *; | [Y] - STEFANIA ZAMPIERI ET AL, "Splicing mutations in glycogen-storage disease type II: evaluation of the full spectrum of mutations and their relation to patients' phenotypes", EUROPEAN JOURNAL OF HUMAN GENETICS, (20101222), vol. 19, no. 4, doi:10.1038/ejhg.2010.188, ISSN 1018-4813, pages 422 - 431, XP055098232 [Y] 1-19 * page 430, column l; table 2 * DOI: http://dx.doi.org/10.1038/ejhg.2010.188 | [Y] - Luis Garcia, "IGBMC - Events, Seminar : RNA-based therapeutics for neuromuscular diseases.", (20140221), URL: http://www.igbmc.fr/events/seminar/1090, (20140905), XP055138404 [Y] 1-19 * abstract * | [A] - RYSZARD KOLE ET AL, "RNA therapeutics: beyond RNA interference and antisense oligonucleotides", NATURE REVIEWS DRUG DISCOVERY, (20120120), vol. 11, no. 2, doi:10.1038/nrd3625, ISSN 1474-1776, pages 125 - 40, XP055138361 [A] 1-19 * figures 2,3 * DOI: http://dx.doi.org/10.1038/nrd3625 | [A] - Anonymous, "Dutch using ZFNs for Pompe disease therapy | SGMO Message Board Posts", (20120112), URL: http://www.investorvillage.com/dialogs/Print.asp?msgid=11339692, (20140905), XP055138466 [A] 1-19 * the whole document * | [A] - HUIE M L ET AL, "Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (- 13T->G) mutation in a majority of patients and a novel IVS10 (+ 1GT -> CT) mutation", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, GB, (199412), vol. 3, no. 12, doi:10.1093/HMG/3.12.2231, ISSN 0964-6906, pages 2231 - 2236, XP008173608 [A] 1-19 * figure 2 * DOI: http://dx.doi.org/10.1093/hmg/3.12.2231 | [A] - A. DARDIS ET AL, "Functional characterization of the common c.-32-13T>G mutation of GAA gene: identification of potential therapeutic agents", NUCLEIC ACIDS RESEARCH, (20131022), vol. 42, no. 2, doi:10.1093/nar/gkt987, ISSN 0305-1048, pages 1291 - 1302, XP055138355 [A] 1-19 * the whole document * DOI: http://dx.doi.org/10.1093/nar/gkt987 | [A] - I-L LU ET AL, "Correction/mutation of acid [alpha]-D-glucosidase gene by modified single-stranded oligonucleotides: in vitro and in vivo studies", GENE THERAPY, (20031002), vol. 10, no. 22, doi:10.1038/sj.gt.3302096, ISSN 0969-7128, pages 1910 - 1916, XP055137931 [A] 1-19 * the whole document * DOI: http://dx.doi.org/10.1038/sj.gt.3302096 | [A] - M. J. A. WOOD ET AL, "RNA-targeted splice-correction therapy for neuromuscular disease", BRAIN, (20100211), vol. 133, no. 4, doi:10.1093/brain/awq002, ISSN 0006-8950, pages 957 - 972, XP055138069 [A] 1-19 * the whole document * DOI: http://dx.doi.org/10.1093/brain/awq002 | [AP] - ATZE J. BERGSMA ET AL, "Identification and Characterization of Aberrant GAA Pre-mRNA Splicing in Pompe Disease Using a Generic Approach", HUMAN MUTATION, (20140922), vol. 36, no. 1, doi:10.1002/humu.22705, ISSN 1059-7794, pages 57 - 68, XP055212207 [AP] 1-19 * the whole document * DOI: http://dx.doi.org/10.1002/humu.22705 | by applicant | US3687808 | US4469863 | US4476301 | US4587044 | US4605735 | US4667025 | US4762779 | US4789737 | US4824941 | US4828979 | US4835263 | US4845205 | US4876335 | US4904582 | US4948882 | US4958013 | US4981957 | US5013830 | US5023243 | US5034506 | US5082830 | US5109124 | US5112963 | US5118800 | US5118802 | US5130302 | US5134066 | US5138045 | US5149797 | US5166315 | US5175273 | US5177196 | US5177198 | US5185444 | US5188897 | US5194599 | US5214134 | US5214136 | US5216141 | US5218105 | US5220007 | US5223618 | US5235033 | US5245022 | US5254469 | US5256775 | US5258506 | US5262536 | US5264423 | US5264562 | US5264564 | WO9324510 | US5272250 | US5276019 | US5278302 | WO9402499 | US5286717 | US5292873 | US5317098 | US5319080 | US5321131 | WO9417093 | US5359044 | US5367066 | US5366878 | WO9426764 | US5371241 | US5378825 | US5386023 | US5391723 | US5393878 | US5399676 | US5403711 | US5405939 | US5405938 | US5414077 | US5416203 | US5432272 | US5434257 | US5446137 | US5451463 | US5453496 | US5455233 | US5457187 | US5459255 | US5466786 | US5466677 | US5470967 | US5476925 | US5484908 | US5486603 | US5489677 | US5491133 | US5502177 | US5506351 | WO9610391 | WO9610390 | WO9610392 | US5508270 | US5510475 | US5512439 | US5512667 | US5514785 | US5519134 | US5519126 | US5525711 | US5525465 | US5527899 | US5536821 | US5539082 | US5541306 | US5541307 | US5541313 | US5545730 | US5550111 | US5552540 | US5552538 | US5561225 | US5563253 | US5565555 | US5565552 | US5565350 | US5567811 | US5567810 | US5571799 | US5574142 | US5576427 | US5578717 | US5578718 | US5580731 | US5585481 | US5587469 | US5587361 | US5587371 | US5591722 | US5591584 | US5594121 | US5596091 | US5596086 | US5595726 | US5597909 | US5597696 | US5599923 | US5599928 | US5602240 | US5608046 | US5610300 | US5610289 | US5614617 | US5618704 | US5623070 | US5623065 | US5625050 | US5627053 | US5633360 | US5639873 | US5646265 | US5645985 | US5646269 | WO9726270 | US5652355 | US5652356 | US5658873 | US5663312 | US5670633 | US5672697 | US5677437 | US5677439 | US5681941 | US5688941 | US5700920 | US5700922 | US5714331 | US5719262 | US5721218 | US5750692 | US5763588 | US5792747 | US5792608 | WO9839352 | US5830653 | WO9914226 | US6005096 | US6007992 | US6028183 | US6043060 | US6127533 | US6147200 | US6268490 | US6287860 | WO0236743 | US6426220 | WO03004602 | US6559279 | US2003158403 | US2003175906 | US2003207804 | US6656730 | US6670461 | US6762169 | US6762281 | US2004219522 | WO2010115993 | WO2012168435 | WO2013053819 | US8501703 | - LIU, S. et al., "Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A", Nucleic Acids Res, (20040000), vol. 32, no. 12, doi:10.1093/nar/gkh715, pages 3752 - 9, XP002376976 DOI: http://dx.doi.org/10.1093/nar/gkh715 | - HENIKOFFHENIKOFF, PNAS, (19920000), vol. 89, pages 10915 - 10919 | - TURNER, CSH Symp. Quant. Biol., (19870000), vol. 1, no. 7, pages 123 - 133 | - FRIER et al., Proc. Nat. Acad. Sci. USA, (19860000), vol. 83, pages 9373 - 77 | - TURNER et al., J. Am. Chem. Soc., (19870000), vol. 109, pages 3783 - 3785 | - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410 | - ZHANGMADDEN, Genome Res., (19970000), vol. 7, pages 649 - 656 | - SMITHWATERMAN, Adv. Appl. Math., (19810000), vol. 2, pages 482 - 489 | - DUNNENANTONARAKIS, Human mutation, (20000000), vol. 15, pages 7 - 12 | - ANTONARAKIS SE, "Recommendations for a nomenclature system for human gene mutations", Hum Mutat, (19980000), vol. 11, pages 1 - 3 | - KURRECK, J., Eur. J. Biochem., (20030000), vol. 270, pages 1628 - 1644 | - WOOLF et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 7305 - 7310 | - MAHERDOLNICK, Nuc. Acid. Res., (19880000), vol. 16, pages 3341 - 3358 | - MARTIN et al., Helv. Chim. Acta, (19950000), vol. 78, pages 486 - 504 | - GALLO et al., Tetrahedron, (20010000), vol. 57, pages 5707 - 5713 | - HARRY-O'KURU et al., J. Org. Chem., (19970000), vol. 62, no. 6, pages 1754 - 1759 | - TANG et al., J. Org. Chem., (19990000), vol. 64, pages 747 - 754 | - KAWASAKI et al., J. Med. Chem., (19930000), vol. 36, pages 831 - 841 | - GUILLERM et al., Bioorganic and Medicinal Chemistry Letters, (19950000), vol. 5, pages 1455 - 1460 | - OWEN et al., J. Org. Chem., (19760000), vol. 41, pages 3010 - 3017 | - JACOBSON et al., J. Med. Chem. Lett., (20000000), vol. 43, pages 2196 - 2203 | - LEE et al., Bioorganic and Medicinal Chemistry Letters, (20010000), vol. 11, pages 1333 - 1337 | - LNA, SINGH et al., Chem. Commun., (19980000), vol. 4, pages 455 - 456 | - MORITA et al., Bioorganic & Medicinal Chemistry Letters, (20020000), vol. 12, pages 73 - 76 | - The Concise Encyclopedia Of Polymer Science And Engineering, John Wiley & Sons, (19900000), pages 858 - 859 | - ENGLISCH et al., Angewandte Chemie, International Edition, (19910000), vol. 30, page 613 | - BEAUCAGETYER, Tetrahedron, (19930000), vol. 49, pages 1925 - 302 | - KURCHAVOV et al., Nucleosides and Nucleotides, (19970000), vol. 16, pages 1837 - 1846 | - LIN, K.-Y.JONES, R. J.MATTEUCCI, M., J. Am. Chem. Soc., (19950000), vol. 117, pages 3873 - 3874 | - WANG, J.LIN, K.-Y.MATTEUCCI, M., Tetrahedron Lett., (19980000), vol. 39, pages 8385 - 8388 | - LIN, K.-Y.MATTEUCCI, M., J. Am. Chem. Soc., (19980000), vol. 120, pages 13252 - 13253 | - FLANAGAN, W. M.WOLF, J. J.OLSON, P.GRANT, D.LIN, K.-Y.WAGNER, R. W.MATTEUCCI, M., Proc. Natl. Acad. Sci. USA, (19990000), vol. 96, pages 3513 - 3518 | - FRIEDEN et al., Nucleic Acids Research, (20030000), vol. 21, no. 14, pages 6365 - 6372 | - DELLINGER et al., J. Am. Chem. Soc., (20030000), vol. 125, pages 856 - 857 | - GRYAZNOV et al., J. Am. Chem. Soc., (19940000), vol. 116, pages 3143 - 3144 | - SKORSKI et al., Proc. Natl. Acad. Sci., (19970000), vol. 94, pages 3966 - 3971 | - FAIRA et al., Nat. Biotechnol., (20010000), vol. 19, pages 40 - 44 | - Chemistry of Nucleosides and Nucleotides, Plenum press, (19880000), vol. 1-3 | - BERGER et al., Nuc Acid Res., (20000000), vol. 28, pages 2911 - 14 | - NIELSEN et al., Science, (19910000), vol. 254, pages 1497 - 1500 | - SAZANI et al., Nat. Biotechnol., (20020000), vol. 20, pages 1228 - 1233 | - DWAINE A. BRAASCHDAVID R. COREY, Biochemistry, (20020000), vol. 41, no. 14, pages 4503 - 4510 | - Genesis, (20010000), vol. 30 | - HEASMAN, J., Dev. Biol., (20020000), vol. 243, pages 209 - 214 | - NASEVICIUS et al., Nat. Genet., (20000000), vol. 26, pages 216 - 220 | - WAHLESTEDT et al., Proc. Natl. Acad. Sci., (20000000), vol. 97, pages 5633 - 5638 | - WANG et al., J. Am. Chem. Soc., (20000000), vol. 122, pages 8595 - 8602 | - ELAYADI et al., Curr. Opinion Invens. Drugs, (20010000), vol. 2, pages 558 - 561 | - BRAASCH et al., Chem. Biol., (20010000), vol. 8, pages 1 - 7 | - ORUM et al., Curr. Opinion Mol. Ther., (20010000), vol. 3, pages 239 - 243 | - MORITA et al., Bioorganic Medicinal Chemistry, (20030000), vol. 11, pages 2211 - 2226 | - BRAASCH et al., Nucleic Acids Research, (20020000), vol. 30, pages 5160 - 5167 | - WAHLESTEDT et al., Proc. Natl. Acad. Sc U.S.A., (20000000), vol. 97, pages 5633 - 5638 | - FLUITER et al., Nucleic Acids Res., (20030000), vol. 31, pages 953 - 962 | - KOSHKIN et al., Tetrahedron, (19980000), vol. 54, pages 3607 - 3630 | - KUMAR et al., Bioorg. Med. Chem. Lett., (19980000), vol. 8, pages 2219 - 2222 | - SINGH et al., J. Org. Chem., (19980000), vol. 63, pages 10035 - 10039 | - Chemical and Engineering News, (20030000), vol. 81, page 9 | - WU et al., Organic Letters, (20020000), vol. 4, no. 8, pages 1279 - 1282 | - STEFFENS et al., Helv. Chim. Acta, (19970000), vol. 80, pages 2426 - 2439 | - STEFFENS et al., J. Am. Chem. Soc., (19990000), vol. 121, pages 3249 - 3255 | - RENNEBERG et al., J. Am. Chem. Soc., (20020000), vol. 124, pages 5993 - 6002 | - RENNEBERG et al., Nucleic acids res., (20020000), vol. 30, pages 2751 - 2757 | - SANGHVI, Nucleic Acids Research, (19930000), vol. 21, pages 3197 - 3203 | - SCARINGE, Methods, (20010000), vol. 23, pages 206 - 217 | - AUSUBEL, F. M. et al., Applications of Chemically synthesized RNA in RNA: Protein Interactions, John Wiley & Sons, Inc., (19980000), vol. 2, pages 1 - 36 | - MARTIN, P., Helvetica Chimica Acta, (19950000), vol. 78, pages 486 - 504 | - Peptide Nucleic Acids (PNA): Synthesis, Properties and Potential Applications, Bioorganic & Medicinal Chemistry, (19960000), vol. 4, pages 5 - 23 | - PERTEA, M.X. LINS.L. SALZBERG, "GeneSplicer: a new computational method for splice site prediction", Nucleic Acids Res, (20010000), vol. 29, no. 5, doi:10.1093/nar/29.5.1185, pages 1185 - 5713, XP002369198 DOI: http://dx.doi.org/10.1093/nar/29.5.1185 | - AUSUBEL, F. M. et al., Current Protocols in Molecular Biology, John Wiley & Sons, Inc., (19910000), vol. 2 | - WU, Z, Mol Ther, (20060000), vol. 14, pages 316 - 27 | - CHOI, VW, J Virol, (20050000), vol. 79, pages 6801 - 07 | - LASIC et al., Chem. Rev., (19950000), vol. 95, pages 2601 - 2627 | - ISHIWATA et al., Chem. Pharm. Bull., (19950000), vol. 43, pages 1005 - 1011 | - LIU et al., J. Biol. Chem., (19950000), vol. 42, pages 24864 - 24870 | - BRANDS, Orphanet J Rare Dis., (20130404), vol. 8, page 51 | - BRANDS et al., Orphanet J Rare Dis, (20130404), vol. 8, page 51 | - HECKMAN, K.L.L.R. PEASE, "Gene splicing and mutagenesis by PCR-driven overlap extension", Nat Protoc, (20070000), vol. 2, no. 4, doi:10.1038/nprot.2007.132, pages 924 - 32, XP055191276 DOI: http://dx.doi.org/10.1038/nprot.2007.132 | - WARLICH E et al., "Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming", Mol Ther., (20110400), vol. 19, no. 4, pages 782 - 9 | - BOYCOTT, K.M. et al., "Rare-disease genetics in the era of next-generation sequencing: discovery to translation", Rev Genet, (20130000), vol. 14, no. 10, doi:10.1038/nrg3555, pages 681 - 91, XP055208827 DOI: http://dx.doi.org/10.1038/nrg3555 | - HAVENS, M.A.D.M. DUELLIM.L. HASTINGS, "Targeting RNA splicing for disease therapy", Wiley Interdiscip Rev RNA, (20130000), vol. 4, no. 3, doi:10.1002/wrna.1158, pages 247 - 66, XP055093642 DOI: http://dx.doi.org/10.1002/wrna.1158 | - DESMET, F.O. et al., "Human Splicing Finder: an online bioinformatics tool to predict splicing signals", Nucleic Acids Res, (20090000), vol. 37, no. 9, page e67 | - YEO, G.C.B. BURGE, "Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals", J Comput Biol, (20040000), vol. 11, no. 2-3, pages 377 - 94, XP002606655 | - REESE, M.G. et al., "Improved splice site detection in Genie", J Comput Biol, (19970000), vol. 4, no. 3, pages 311 - 23, XP009027584 | - PALACIOS, I.M., "Nonsense-mediated mRNA decay: from mechanistic insights to impacts on human health", Brief Funct Genomics, (20130000), vol. 12, no. 1, pages 25 - 36 | - VAN DER PLOEG, A.T.A.J. REUSER, "Pompe's disease", Lancet, (20080000), vol. 372, no. 9646, pages 1342 - 53 | - UMAPATHYSIVAM, K.J.J. HOPWOODP.J. MEIKLE, "Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease", Clin Chim Acta, (20050000), vol. 361, no. 1-2, pages 191 - 8 | - VAN DEN HOUT, H. et al., "Recombinant human alpha-glucosidase from rabbit milk in Pompe patients", Lancet, (20000000), vol. 356, no. 9227, doi:10.1016/S0140-6736(00)02533-2, pages 397 - 8, XP002426732 DOI: http://dx.doi.org/10.1016/S0140-6736(00)02533-2 | - KISHNANI, P. et al., "Enzyme replacement therapy with recombinant human acid alpha glucosidase (rhGAA) in infantile Pompe disease (IPD): Results from a Phase 2 study", Pediatric Research, (20030000), vol. 53, no. 4, pages 259a - 259a | - KISHNANI, P.S. et al., "Recombinant human acid alpha-glucosidase - Major clinical benefits in infantile-onset Pompe disease", Neurology, (20070000), vol. 68, no. 2, pages 99 - 109 | - GUNGOR, D. et al., "Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study", Orphanet Journal of Rare Diseases, (20130000), page 8 | - DEN DUNNEN, J.T.S.E. ANTONARAKIS, "Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion", Human Mutation, (20000000), vol. 15, no. 1, doi:10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N, pages 7 - 12, XP009002792 DOI: http://dx.doi.org/10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N | - BUTTERWORTH, J.D.M. DROADHEAD, "Diagnosis of Pompe's disease in cultured skin fibroblasts and primary amniotic fluid cells using 4-methylumbelliferyl-alpha-D-glucopyranoside as substrate", Clin Chim Acta, (19770000), vol. 78, no. 2, pages 335 - 42 | - PICKRELL, J.K. et al., "Noisy splicing drives mRNA isoform diversity in human cells", PLoS Genet, (20100000), vol. 6, no. 12, page e1001236 | - HUIE, M.L. et al., "Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation", Hum Mol Genet, (19940000), vol. 3, no. 12, doi:10.1093/hmg/3.12.2231, pages 2231 - 6, XP008173608 DOI: http://dx.doi.org/10.1093/hmg/3.12.2231 | - BOERKOEL, C.F. et al., "Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II", Am J Hum Genet, (19950000), vol. 56, no. 4, pages 887 - 97 | - PITTIS, M.G. et al., "Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease", Hum Mutat, (20080000), vol. 29, no. 6, pages E27 - 36 | - DARDIS, A. et al., "Functional characterization of the common c.-32-13T>G mutation of GAA gene: identification of potential therapeutic agents", Nucleic Acids Res, (20140000), vol. 42, no. 2, doi:10.1093/nar/gkt987, pages 1291 - 302, XP055138355 DOI: http://dx.doi.org/10.1093/nar/gkt987 | - HERMANS, M.M. et al., "The effect of a single base pair deletion (delta T525) and a C1634T missense mutation (pro5451eu) on the expression of lysosomal alpha-glucosidase in patients with glycogen storage disease type II", Hum Mol Genet, (19940000), vol. 3, no. 12, pages 2213 - 8 | - HERMANS, M.M. et al., "Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II", Hum Mutat, (20040000), vol. 23, no. 1, pages 47 - 56 | - ORLIKOWSKI, D. et al., "Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease", Neuromuscul Disord, (20110000), vol. 21, no. 7, doi:10.1016/j.nmd.2011.04.001, pages 477 - 82, XP028100320 DOI: http://dx.doi.org/10.1016/j.nmd.2011.04.001 | - STROPPIANO, M. et al., "Aberrant splicing at catalytic site as cause of infantile onset glycogen storage disease type II (GSDII): molecular identification of a novel IVS9 (+2GT-->GC) in combination with rare IVS10 (+1GT-->CT", Am J Med Genet, (20010000), vol. 101, no. 1, pages 55 - 8 | - MULLER-FELBER, W. et al., "Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients", Neuromuscul Disord, (20070000), vol. 17, no. 9-10, doi:10.1016/j.nmd.2007.06.002, pages 698 - 706, XP022325967 DOI: http://dx.doi.org/10.1016/j.nmd.2007.06.002 | - KROOS, M. et al., "Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants", Hum Mutat, (20120000), vol. 33, no. 8, doi:10.1002/humu.22108, pages 1161 - 5, XP055098231 DOI: http://dx.doi.org/10.1002/humu.22108 | - KROOS, M. et al., "Seven cases of Pompe disease from Greece", J Inherit Metab Dis, (20060000), vol. 29, no. 4, doi:10.1007/s10545-006-0280-5, pages 556 - 63, XP019392105 DOI: http://dx.doi.org/10.1007/s10545-006-0280-5 | - BARBOSA-MORAIS, N.L. et al., "The evolutionary landscape of alternative splicing in vertebrate species", Science, (20120000), vol. 338, no. 6114, pages 1587 - 93 | - WANG, G.ST.A. COOPER, "Splicing in disease: disruption of the splicing code and the decoding machinery", Nat Rev Genet, (20070000), vol. 8, no. 10, doi:10.1038/nrg2164, pages 749 - 61, XP055779697 DOI: http://dx.doi.org/10.1038/nrg2164 | - KWAN, T. et al., "Genome-wide analysis of transcript isoform variation in humans", Nat Genet, (20080000), vol. 40, no. 2, doi:10.1038/ng.2007.57, pages 225 - 31, XP037115615 DOI: http://dx.doi.org/10.1038/ng.2007.57 | - CASTLE, J.C. et al., "Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines", Nat Genet, (20080000), vol. 40, no. 12, pages 1416 - 25 | - WANG, E.T. et al., "Alternative isoform regulation in human tissue transcriptomes", Nature, (20080000), vol. 456, no. 7221, doi:10.1038/nature07509, pages 470 - 6, XP055596760 DOI: http://dx.doi.org/10.1038/nature07509 | - LAPPALAINEN, T. et al., "Transcriptome and genome sequencing uncovers functional variation in humans", Nature, (20130000), vol. 501, no. 7468, doi:10.1038/nature12531, pages 506 - 11, XP055767730 DOI: http://dx.doi.org/10.1038/nature12531 | - LALONDE, E. et al., "RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression", Genome Res, (20110000), vol. 21, no. 4, pages 545 - 54 | - WOKKE, J.H. et al., "Genotype-phenotype correlation in adult-onset acid maltase deficiency", Ann Neurol, (19950000), vol. 38, no. 3, pages 450 - 4 | - KISHNANI, P.S. et al., "Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants", Mol Genet Metab, (20100000), vol. 99, no. 1, pages 26 - 33, XP026802467 | - LIM, K.H. et al., "Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes", Proc Natl Acad Sci USA, (20110000), vol. 108, no. 27, pages 11093 - 8 | - FAN, L. et al., "Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing", ACS Chem Biol, (20110000), vol. 6, no. 6, doi:10.1021/cb100356k, pages 582 - 9, XP055112383 DOI: http://dx.doi.org/10.1021/cb100356k | - WEBB, T.R.A.S. JOYNERP.M. POTTER, "The development and application of small molecule modulators of SF3b as therapeutic agents for cancer", Drug Discov Today, (20130000), vol. 18, no. 1-2, doi:10.1016/j.drudis.2012.07.013, pages 43 - 9, XP055684932 DOI: http://dx.doi.org/10.1016/j.drudis.2012.07.013 | - WARLICH, E. et al., "Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming", Mol Ther, (20110000), vol. 19, no. 4, pages 782 - 9 | WO1992US09196 | WO1993US06976 | WO1994US00902 | WO2014NL50375 |